BioSpace News Archive

Twist Bioscience Corporation today announced that it has priced its initial public offering of 5,000,000 shares of its common stock at a price to the public of $14.00 per share, before underwriting discounts and commissions.

Axonics Modulation Technologies, Inc. today announced the pricing of its initial public offering of 8,000,000 shares of common stock at an initial public offering price of $15.00 per share, before underwriting discounts and commissions.

FDA approval of RECELL® System for the treatment of acute thermal burns in adults

Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), parent company of Lantheus Medical Imaging, Inc. (“LMI”), a global leader in the development, manufacture and commercialization of innovative diagnostic imaging agents and products, today reported financial results for its third quarter ended September 30, 2018.

Data from PharmaForce International’s Deployment Analyzer indicates that U.S. pharmaceutical companies focusing on vaccine deployment have moved their sales forces toward a more specialized approach.

Danaher Corporation announced that President and Chief Executive Officer, Thomas P. Joyce, Jr., will be presenting at the Baird Global Industrial Conference in Chicago on Tuesday, November 6, 2018 at 9:30 a.m. CT.

Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for peripheral and coronary artery disease, today reported financial results for its fiscal first quarter, ended September 30, 2018.

Clovis Oncology, Inc. (NASDAQ:CLVS) reported financial results for the quarter ended September 30, 2018, and provided an update on the Company’s clinical development programs and regulatory and commercial outlook for the remainder of 2018.

-- Conference Call Scheduled for Thursday, November 8, 2018 at 4:30 p.m. EDT --

Corindus Vascular Robotics, Inc. (NYSE American: CVRS), a leading developer of precision vascular robotics, today announced that it will release financial and business results for the third quarter of 2018 on Tuesday, November 6, 2018